No association between the Plasmodium vivax crt-o MS334 or In9pvcrt polymorphisms and chloroquine failure in a clinical cohort from Malaysia
View ORCID ProfileAngela Rumaseb, Roberto R. Moraes Barros, View ORCID ProfileJuliana M. Sá, View ORCID ProfileJonathan J. Juliano, Timothy William, View ORCID ProfileKamil A. Braima, View ORCID ProfileBridget E. Barber, View ORCID ProfileNicholas M Anstey, View ORCID ProfileRic N. Price, View ORCID ProfileMatthew J. Grigg, View ORCID ProfileSarah Auburn, View ORCID ProfileJutta Marfurt
doi: https://doi.org/10.1101/2022.11.30.22282917
Angela Rumaseb
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
Roberto R. Moraes Barros
2Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
Juliana M. Sá
2Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA
Jonathan J. Juliano
3Division of Infectious Diseases, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Timothy William
4Clinical Research Centre, Queen Elizabeth Hospital, Sabah, Malaysia
5Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Sabah, Malaysia
Kamil A. Braima
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
Bridget E. Barber
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
6QIMR Berghofer Medical Research Institute, Brisbane, Australia
Nicholas M Anstey
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
5Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Sabah, Malaysia
Ric N. Price
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
7Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
8Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand
Matthew J. Grigg
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
5Infectious Diseases Society Sabah-Menzies School of Health Research Clinical Research Unit, Kota Kinabalu, Sabah, Malaysia
Sarah Auburn
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
7Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
8Mahidol-Oxford Tropical Medicine Research Unit, Mahidol University, Bangkok, Thailand
Jutta Marfurt
1Global and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia
9College of Medicine and Public Health, Flinders University, Darwin, Northern Territory, Australia
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data produced in the present work are contained in the manuscript
Posted December 01, 2022.
No association between the Plasmodium vivax crt-o MS334 or In9pvcrt polymorphisms and chloroquine failure in a clinical cohort from Malaysia
Angela Rumaseb, Roberto R. Moraes Barros, Juliana M. Sá, Jonathan J. Juliano, Timothy William, Kamil A. Braima, Bridget E. Barber, Nicholas M Anstey, Ric N. Price, Matthew J. Grigg, Sarah Auburn, Jutta Marfurt
medRxiv 2022.11.30.22282917; doi: https://doi.org/10.1101/2022.11.30.22282917
No association between the Plasmodium vivax crt-o MS334 or In9pvcrt polymorphisms and chloroquine failure in a clinical cohort from Malaysia
Angela Rumaseb, Roberto R. Moraes Barros, Juliana M. Sá, Jonathan J. Juliano, Timothy William, Kamil A. Braima, Bridget E. Barber, Nicholas M Anstey, Ric N. Price, Matthew J. Grigg, Sarah Auburn, Jutta Marfurt
medRxiv 2022.11.30.22282917; doi: https://doi.org/10.1101/2022.11.30.22282917
Subject Area
Subject Areas
- Addiction Medicine (331)
- Allergy and Immunology (653)
- Anesthesia (174)
- Cardiovascular Medicine (2542)
- Dermatology (212)
- Emergency Medicine (387)
- Epidemiology (12019)
- Forensic Medicine (10)
- Gastroenterology (724)
- Genetic and Genomic Medicine (3936)
- Geriatric Medicine (369)
- Health Economics (659)
- Health Informatics (2540)
- Health Policy (980)
- Hematology (354)
- HIV/AIDS (816)
- Medical Education (391)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3701)
- Nursing (205)
- Nutrition (550)
- Oncology (1922)
- Ophthalmology (560)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1081)
- Primary Care Research (437)
- Public and Global Health (6371)
- Radiology and Imaging (1344)
- Respiratory Medicine (849)
- Rheumatology (389)
- Sports Medicine (336)
- Surgery (427)
- Toxicology (51)
- Transplantation (184)
- Urology (159)